000 01590 a2200421 4500
005 20250518093644.0
264 0 _c20200407
008 202004s 0 0 eng d
022 _a2047-9980
024 7 _a10.1161/JAHA.120.016509
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aSommerstein, Rami
245 0 0 _aCoronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors/Angiotensin Receptor Blockers Have a Biphasic Effect?
_h[electronic resource]
260 _bJournal of the American Heart Association
_c04 2020
300 _ae016509 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAngiotensin Receptor Antagonists
_xadverse effects
650 0 4 _aAngiotensin-Converting Enzyme 2
650 0 4 _aAngiotensin-Converting Enzyme Inhibitors
_xadverse effects
650 0 4 _aBetacoronavirus
_xdrug effects
650 0 4 _aCOVID-19
650 0 4 _aCardiovascular Diseases
_xcomplications
650 0 4 _aComorbidity
650 0 4 _aCoronavirus Infections
_xcomplications
650 0 4 _aDisease Notification
650 0 4 _aHumans
650 0 4 _aPandemics
650 0 4 _aPeptidyl-Dipeptidase A
_xdrug effects
650 0 4 _aPneumonia, Viral
_xcomplications
650 0 4 _aRisk Factors
650 0 4 _aSARS-CoV-2
650 0 4 _aSeverity of Illness Index
700 1 _aKochen, Michael M
700 1 _aMesserli, Franz H
700 1 _aGräni, Christoph
773 0 _tJournal of the American Heart Association
_gvol. 9
_gno. 7
_gp. e016509
856 4 0 _uhttps://doi.org/10.1161/JAHA.120.016509
_zAvailable from publisher's website
999 _c30801486
_d30801486